Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Restless leg syndrome/Willis-Ekbom disease has brain iron deficiency that produces excessive dopamine and known genetic risks, some of which contribute to the brain iron deficiency. Dopamine treatments work temporarily but may eventually produce further postsynaptic down-regulation and worse restless leg syndrome. This article includes sections focused on pathophysiologic findings from each of these areas: genetics, cortical-spinal excitability, and iron and dopamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Winkelmann, J., Schormair, B., Lichtner, P., Ripke, S., Xiong, L., Jalilzadeh, S., Fulda, S., Pütz, B., Eckstein, G., Hauk, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2099 · Cited by 704
A Genetic Risk Factor for Periodic Limb Movements in Sleep
Stefansson, H., Rye, D. B., Hicks, A., Petursson, H., Ingason, A., Thorgeirsson, T. E., Palsson, S., Sigmundsson, T., Sigurdsson, A. P., Eiriksdottir, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072743 · Cited by 630
Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome
Earley, C. J., Connor, J. R., Beard, J. L., Malecki, E. A., Epstein, D. K., & Allen, R. P. (2000) · Neurology · doi:10.1212/wnl.54.8.1698 · Cited by 616 · cited 1×
“Reduced cerebrospinal fluid (CSF) ferritin was reported in 2 separate studies for RLS/WED patients who had normal peripheral iron measures.(14,15) The single best-documented biological abnormality for RLS/WED is brain iron deficiency.”
BackgroundSelf-citationMRI measurement of brain iron in patients with restless legs syndrome
Allen, R. P., Barker, P. B., Wehrl, F., Song, H. K., & Earley, C. J. (2001) · Neurology · doi:10.1212/wnl.56.2.263 · Cited by 570
Self-citationIron and The Restless Legs Syndrome
Sun, E. R., Chen, C. A., Ho, G., Earley, C. J., & Allen, R. P. (1998) · Sleep · doi:10.1093/sleep/21.4.381 · Cited by 466
Self-citationStriatal dopaminergic function in restless legs syndrome: 18F-dopa and11C-raclopride PET studies
Turjanski, N., Lees, A. J., & Brooks, D. J. (1999) · Neurology · doi:10.1212/wnl.52.5.932 · Cited by 416
Iron deficiency decreases dopamine D1 and D2 receptors in rat brain
Erikson, K. M., Jones, B. C., Hess, E. J., Zhang, Q., & Beard, J. L. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00563-9 · Cited by 335
PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome
Schormair, B., Kemlink, D., Roeske, D., Eckstein, G., Xiong, L., Lichtner, P., Ripke, S., Trenkwalder, C., Zimprich, A., Stiasny-Kolster, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.190 · Cited by 287
CSF iron, ferritin and transferrin levels in restless legs syndrome
MIZUNO, S., MIHARA, T., MIYAOKA, T., INAGAKI, T., & HORIGUCHI, J. (2005) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2004.00403.x · Cited by 285 · cited 1×
“Reduced cerebrospinal fluid (CSF) ferritin was reported in 2 separate studies for RLS/WED patients who had normal peripheral iron measures.(14,15) The single best-documented biological abnormality for RLS/WED is brain iron deficiency.”
BackgroundMichaud, M., Soucy, J.-P., Chabli, A., Lavigne, G., & Montplaisir, J. (2002) · Journal of Neurology · doi:10.1007/pl00007859 · Cited by 278
Iron Deficiency Alters Dopamine Transporter Functioning in Rat Striatum
Erikson, K. M., Jones, B. C., & Beard, J. L. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.11.2831 · Cited by 272 · cited 2×
“Iron-deficient rodents show decreased D2 receptors similar to that seen in RLS/WED42; they also show a decreased DAT, mostly membrane-bound DAT.43 Initial single-photon emission computerized tomography studies of total DAT generally found no significant differences between RLS/WED and controls,39 but membrane-bound DA…”
BackgroundOrtiz, E., Pasquini, J. M., Thompson, K., Felt, B., Butkus, G., Beard, J., & Connor, J. R. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20207 · Cited by 260 · cited 1×
“Myelin synthesis depends on iron, and brain iron deficiency in animals reduces myelin proteins, lipids, and cholesterol.(33,34) The brain iron deficiency of RLS/WED would be expected to produce a mild but significant myelin deficit.”
BackgroundSupport for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding
Cervenka, S. (2006) · Brain · doi:10.1093/brain/awl163 · Cited by 252 · cited 1×
“A later study reported increased D2 receptor binding, indicating the opposite of a decreased synaptic dopamine, but that study had mostly mildly affected patients.(41) The fluoro-L-dopa (fDOPA) studies, in contrast, have consistently shown decreased striatal fDOPA uptake.”
ResultMRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome
Earley, C. J., B. Barker, P., Horská, A., & Allen, R. P. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.11.009 · Cited by 249
Self-citationThe prevalence and impact of restless legs syndrome on patients with iron deficiency anemia
Allen, R. P., Auerbach, S., Bahrain, H., Auerbach, M., & Earley, C. J. (2013) · American Journal of Hematology · doi:10.1002/ajh.23397 · Cited by 246 · cited 1×
“) in iron-deficient anemia than general populations.(13) All conditions that compromise iron status have been associated with increased risk of RLS/ WED (eg, pregnancy and end-stage renal disease).”
BackgroundSelf-citationProfile of altered brain iron acquisition in restless legs syndrome
Connor, J. R., Ponnuru, P., Wang, X.-S., Patton, S. M., Allen, R. P., & Earley, C. J. (2011) · Brain · doi:10.1093/brain/awr012 · Cited by 243 · cited 2×
“The iron regulatory proteins in the choroid plexus are increased for the cellular iron intake (transferrin receptor, transferrin) but also iron export (ferroportin).(23) Thus, these cells show a pattern consistent with a higher turnover of iron feeding an increasedmitochondrial iron status.”
BackgroundSelf-citationAugmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)
Winkelman, J. W., & Johnston, L. (2004) · Sleep Medicine · doi:10.1016/j.sleep.2003.07.005 · Cited by 217 · cited 1×
“Tolerance is the first step.(46) Eventually, over time, the adjustment of the system to even more increased dopamine produces a gradual worsening of the RLS.”
BackgroundDecreased transferrin receptor expression by Neuromelanin cells in restless legs syndrome
Connor, J. R., Wang, X. S., Patton, S. M., Menzies, S. L., Troncoso, J. C., Earley, C. J., & Allen, R. P. (2004) · Neurology · doi:10.1212/01.wnl.0000123251.60485.ac · Cited by 199 · cited 1×
“This finding may relate to a decreased activity of iron regulatory protein-1.(22) The transport of iron into the brain shows a more complete picture.”
BackgroundSelf-citationTranscranial ultrasound shows nigral hypoechogenicity in restless legs syndrome
Schmidauer, C., Sojer, M., Seppi, K., Stockner, H., Högl, B., Biedermann, B., Brandauer, E., Peralta, C. M., Wenning, G. K., & Poewe, W. (2005) · Annals of Neurology · doi:10.1002/ana.20572 · Cited by 195
Winkelmann, J., Czamara, D., Schormair, B., Knauf, F., Schulte, E. C., Trenkwalder, C., Dauvilliers, Y., Polo, O., Högl, B., Berger, K., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002171 · Cited by 193
Self-citationNORDLANDER, N. B. (1953) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1953.tb07042.x · Cited by 191 · cited 2×
“This deficiency was noted in the seminal RLS/WED studies of Ekbom(10) and Nordlander.(11) RLS/WED severity increases with decreased peripheral iron,(12) and its prevalence is about 9 times greater”
BackgroundThe Dopamine Transporter is Decreased in the Striatum of Subjects with Restless Legs Syndrome
Earley, C. J., Kuwabara, H., Wong, D. F., Gamaldo, C. E., Salas, R. M. E., Brašić, J. R., Ravert, H. T., Dannals, R. F., & Allen, R. P. (2011) · SLEEP · doi:10.1093/sleep/34.3.341 · Cited by 169 · cited 1×
“Initial single-photon emission computerized tomography studies of total DAT generally found no significant differences between RLS/WED and controls,(39) but membrane-bound DAT was found decreased in 2 separate studies reported together.(44) The decreased DAT was found with methylphenidate binding (Fig.”
Self-citationOertel, W. H., Trenkwalder, C., Beneš, H., Ferini‐Strambi, L., Högl, B., Poewe, W. H., Stiasny‐Kolster, K., Fichtner, A., Schollmayer, E., Kohnen, R., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70127-2 · Cited by 157 · cited 1×
“at the 4-mg and higher doses).(47) Overall, the RLS/ WED pathophysiology of dopamine indicates that dopamine medications often have a limited lifespan for effective treatment, and other agents will be needed.”
BackgroundEffect of prenatal iron deficiency on myelination in rat pups.
Yu, G. S., Steinkirchner, T. M., Rao, G. A., & Larkin, E. C. (1986) · PubMed Central · Cited by 156
Benediktsdóttir, B., Janson, C., Lindberg, E., Arnardóttir, E. S., Ólafsson, Í., Cook, E., Thorarinsdottir, E. H., & Gíslason, Þ. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.08.006 · Cited by 155
Multiregional brain iron deficiency in restless legs syndrome
Godau, J., Klose, U., Santo, A. D., Schweitzer, K. J., & Berg, D. (2008) · Movement Disorders · doi:10.1002/mds.22070 · Cited by 149
Peripheral hypoxia in restless legs syndrome (Willis-Ekbom disease)
Salminen, A. V., Rimpilä, V., & Polo, O. J. (2014) · Neurology · doi:10.1212/wnl.0000000000000454 · Cited by 136 · cited 1×
“Some recent studies have suggested an increased difference between morning and evening blood flow(28) and relative hypoxia in leg muscles of RLS/WED patients.(29) It may be that hypoxia or hypoxic pathway activation is one pathway to RLS/WED symptoms.”
BackgroundLow brain iron content in idiopathic restless legs syndrome patients detected by phase imaging
Rizzo, G., Manners, D. N., Testa, C. M., Tonon, C., Vetrugno, R., Marconi, S., Plazzi, G., Pizza, F., Provini, F., Malucelli, E., et al. (2013) · Movement Disorders · doi:10.1002/mds.25576 · Cited by 123 · cited 1×
“Recent studies with more sensitive measures have documented low iron in the thalamus.(20) The iron deficiency seems to be more regional than global, and the affected regions include not only iron rich areas such as the substantia nigra but also iron-poor areas, particularly the thalamus.”
BackgroundIncreased Synaptic Dopamine in the Putamen in Restless Legs Syndrome
Earley, C. J., Kuwabara, H., Wong, D. F., Gamaldo, C. E., Salas, R. M. E., Brašić, J. R., Ravert, H. T., Dannals, R. F., & Allen, R. P. (2013) · SLEEP · doi:10.5665/sleep.2300 · Cited by 122 · cited 1×
“Thus, overall, the brain imaging studies also indicate increased striatal dopamine, not the expected decrease.(45)”
BackgroundSelf-citationMoore, H. E., Winkelmann, J., Lin, L., Finn, L. A., Peppard, P. E., & Mignot, E. J.-M. (2014) · SLEEP · doi:10.5665/sleep.4006 · Cited by 121 · cited 3×
“The well-defined RLS/WED phenotype enabled successful genomewide association studies (GWAS) that have now identified RLS/WED risk alleles on 5 specific genomic regions for MEIS1, BTBD9, PTPRD, MAP2k/SKOR1, and TOX3/ BC034767 and on an intergenic region on chromosome 2 (rs6747972).1–3 Most of these variants also seem t…”
BackgroundWalters, A. S., Ondo, W. G., Zhu, W., & Le, W. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.022 · Cited by 115 · cited 1×
“Loss of cells has not generally been reported (eg, A11 dopamine cells(55)) except in one study that reported a decrease in thalamic cells staining for beta endorphin.(56) This, finding, however, needs to be confirmed.”
ResultLanza, G., Cantone, M., Lanuzza, B., Pennisi, M., Bella, R., Pennisi, G., & Ferri, R. (2014) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.04.001 · Cited by 113
Hypoxia‐inducible factor pathway activation in restless legs syndrome patients
Patton, S. M., Ponnuru, P., Snyder, A. M., Podskalny, G. D., & Connor, J. R. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03397.x · Cited by 111 · cited 1×
“The hypoxic inducible factor 2-alpha and the vascular endothelial growth factor were increased in the microvessels.(25) These differences occurred despite the lack of any significant indication of actual hypoxia.”
BackgroundUnrath, A., Juengling, F. D., Schork, M., & Kassubek, J. (2007) · Movement Disorders · doi:10.1002/mds.21608 · Cited by 101
DeAndrade, M. P., Johnson, R. L., Unger, E. L., Zhang, L., van Groen, T., Gamble, K. L., & Li, Y. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds221 · Cited by 97
The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal
Earley, C. J., Allen, R. P., Connor, J. R., Ferrucci, L., & Troncoso, J. C. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2009.01.006 · Cited by 95
Self-citationPostmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome
Connor, J. R., Ponnuru, P., Lee, B., Podskalny, G. D., Alam, S., Allen, R. P., Earley, C. J., & Yang, Q. X. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.10.009 · Cited by 91 · cited 2×
“Postmortem analyses also found a 25% decrease in myelin proteins.(35) This degree of myelin deficit could contribute to the RLS/WED symptoms, particularly in relation to sensorimotor integration that has time-dependent signaling.”
BackgroundSelf-citationIncreased frequency of restless legs syndrome in chronic obstructive pulmonary disease patients
Coco, D. L., Mattaliano, A., Coco, A. L., & Randisi, B. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2008.04.014 · Cited by 76
Mitochondrial Ferritin in the Substantia Nigra in Restless Legs Syndrome
Snyder, A. M., Wang, X., Patton, S. M., Arosio, P., Levi, S., Earley, C. J., Allen, R. P., & Connor, J. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181bdc44f · Cited by 74 · cited 1×
“The increased mitochondrial ferritin was also found in the cells of the substantia nigra but not the putamen.(24) In these cells there seemed to be more mitochondria and increased iron demand.”
BackgroundSelf-citationUnrath, A., Müller, H., Ludolph, A. C., Riecker, A., & Kassubek, J. (2008) · Movement Disorders · doi:10.1002/mds.22074 · Cited by 71 · cited 2×
“There are, however, consistent reports of regional white matter decrease in RLS/WED consistent with the expected effects of iron deficiency as noted before.(35,62,63) An anatomic locus significant for RLS/WED symptoms has been suggested based on theoretic considerations and findings of dopamine, iron abnormalities, TM…”
BackgroundVoxel-based morphometry in unmedicated patients with restless legs syndrome
Hornyak, M., Ahrendts, J., Spiegelhalder, K., Riemann, D. W., Voderholzer, U., Feige, B., & van Elst, L. T. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.09.010 · Cited by 68
Lanza, G., Lanuzza, B., Aricò, D., Cantone, M., Cosentino, F., Pennisi, M., Bella, R., Pennisi, G., & Ferri, R. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.08.016 · Cited by 64
Stiasny‐Kolster, K., Möller, J. C., Zschocke, J., Bandmann, O., Cassel, W., Oertel, W. H., & Hoffmann, G. F. (2003) · Movement Disorders · doi:10.1002/mds.10631 · Cited by 63 · cited 1×
“The initial CSF analyses showed no differences between RLS/WED and controls for the major proteins related to dopamine.(36,37) A repeat analysis of 3-orthymethyl dopamine (3-OMD) found significant increases in the CSF in 2 independent samples (Fig.”
BackgroundMotor cortex excitability in restless legs syndrome
Scalise, A., Pittaro-Cadore, I., & Gigli, G. L. (2004) · Sleep Medicine · doi:10.1016/j.sleep.2004.01.011 · Cited by 58
Wåhlin‐Larsson, B., Ulfberg, J., Aulin, K. P., & Kadi, F. (2009) · Muscle & Nerve · doi:10.1002/mus.21357 · Cited by 58
Dopamine agonists restore cortical plasticity in patients with idiopathic restless legs syndrome
Rizzo, V., Aricò, I., Mastroeni, C., Morgante, F., Liotta, G., Girlanda, P., Silvestri, R., & Quartarone, A. (2008) · Movement Disorders · doi:10.1002/mds.22436 · Cited by 56
Lack of specific gray matter alterations in restless legs syndrome in elderly subjects
Celle, S., Roche, F., Peyron, R., Faillenot, I., Laurent, B., Pichot, V., Barthélemy, J., & Sforza, E. A. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5320-2 · Cited by 53
Skeletal Muscle Morphology in Patients with Restless Legs Syndrome
Wåhlin‐Larsson, B., Kadi, F., Ulfberg, J., & Aulin, K. P. (2007) · European Neurology · doi:10.1159/000104712 · Cited by 48 · cited 1×
“These could represent a sequelae of a general iron regulation problem.(26,27) Some recent studies have suggested an increased difference between morning and evening blood flow(28) and relative hypoxia in leg muscles of RLS/WED patients.”
BackgroundGray matter alteration in patients with restless legs syndrome: a voxel-based morphometry study
Chang, Y., Chang, H. W., Song, H., Ku, J. H., Earley, C. J., Allen, R. P., & Cho, Y. W. (2014) · Clinical Imaging · doi:10.1016/j.clinimag.2014.07.010 · Cited by 47
Self-citationChanges of cortical excitability after dopaminergic treatment in restless legs syndrome
Scalise, A., Pittaro-Cadore, I., Janes, F., Marinig, R., & Gigli, G. L. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2009.05.003 · Cited by 47
Moon, H., Chang, Y., Lee, Y. S., Song, H.-J., Chang, H. W., Ku, J. H., & Cho, Y. W. (2014) · Journal of Clinical Neurology · doi:10.3988/jcn.2014.10.3.197 · Cited by 47
Comley, R. A., Červenka, S., Pålhagen, S., et al. (2010) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2010.00536.x · Cited by 45
Systems genetic analysis of the effects of iron deficiency in mouse brain
Jellen, L. C., Unger, E. L., Lu, L., Williams, R. W., Rousseau, S., Wang, X., Earley, C. J., Allen, R. P., Miles, M. F., & Jones, B. C. (2012) · Neurogenetics · doi:10.1007/s10048-012-0321-1 · Cited by 45 · cited 2×
“The well-defined RLS/WED phenotype enabled successful genomewide association studies (GWAS) that have now identified RLS/WED risk alleles on 5 specific genomic regions for MEIS1, BTBD9, PTPRD, MAP2k/SKOR1, and TOX3/ BC034767 and on an intergenic region on chromosome 2 (rs6747972).1–3 Most of these variants also seem t…”
BackgroundSelf-citationRestless Legs Syndrome in Patients with Chronic Obstructive Pulmonary Disease
Kaplan, Y., İnönü, H., Yılmaz, A. T., & Öcal, S. (2008) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100008957 · Cited by 43
A genetic risk factor for low serum ferritin levels in Danish blood donors
Sørensen, E., Grau, K., Berg, T., Simonsen, A. C., Magnussen, K., Erikstrup, C., Hansen, M. B., & Ullum, H. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03629.x · Cited by 41 · cited 1×
“Another BDBT9 allelic variant relates to RLS/WED diagnosis,(3) increased PLMS,(6) and greater decreases in peripheral iron stores with blood donations.(7) Functional relation of BTBD9 has been further indicated by findings of increased peripheral iron for a BDBT9-mutant mouse(8) and murine ventral midbrain iron conten…”
BackgroundAltered Iron Metabolism in Lymphocytes from Subjects with Restless Legs Syndrome
Earley, C. J., Ponnuru, P., Wang, X., Patton, S. M., Connor, J. R., Beard, J. L., Taub, D. D., & Allen, R. P. (2008) · SLEEP · doi:10.1093/sleep/31.6.847 · Cited by 41 · cited 1×
“The iron-related abnormalities have even been found in the lymphocytes.(64) But iron is probably not the whole picture.”
BackgroundSelf-citationChang, Y., Paik, J.-S., Lee, H. J., Chang, H. W., Moon, H., Allen, R. P., Earley, C. J., & Cho, Y. W. (2014) · Neurological Research · doi:10.1179/1743132814y.0000000336 · Cited by 36 · cited 1×
“There are, however, consistent reports of regional white matter decrease in RLS/WED consistent with the expected effects of iron deficiency as noted before.(35,62,63) An anatomic locus significant for RLS/WED symptoms has been suggested based on theoretic considerations and findings of dopamine, iron abnormalities, TM…”
Self-citationInfluence of Cabergoline on Motor Excitability in Patients With Restless Legs Syndrome
Gorsler, A., & Liepert, J. (2007) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e31815a0038 · Cited by 32
Cited by
Manconi, M., Garcia-Borreguero, D., Schormair, B., Videnovic, A., Berger, K., Ferri, R., & Dauvilliers, Y. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00311-z · Cited by 271
Metadata
- Authors
- Allen, R. P.
- Venue
- Sleep Medicine Clinics
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 10
- Issue
- 3
- Pages
- 207-214
- ISSN
- 1556-407X (ISSN-L)
- OpenAlex
- W2142086028
- Cited by
- 199
- References
- 58
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.